Yu Takeuchi

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 187 citations

Jasmitt Study, Clinical Injury, Neurological Disorder +10

AtPHT4;4 is a chloroplast-localized ascorbate transporter in Arabidopsis

Takaaki Miyaji, Takashi Kuromori, Yu Takeuchi et al. · Nature Communications · 2015 · 177 citations · Full text

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki et al. · Annals of Neurology · 2009 · 156 citations

CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA

Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno et al. · Brain · 2007 · 120 citations · Full text

Walking capacity evaluated by the 6‐minute walk test in spinal and bulbar muscular atrophy

Yu Takeuchi, Masahisa Katsuno, Haruhiko Banno et al. · Muscle & Nerve · 2008 · 62 citations

Physical Activity, Movement Biomechanics, Neurochemical Biomarkers +19